WallStreetZenWallStreetZen

NASDAQ: SLP
Simulations Plus Inc Stock

$40.46-0.22 (-0.54%)
Updated Sep 26, 2023
SLP Price
$40.46
Fair Value Price
$43.17
Market Cap
$806.24M
52 Week Low
$32.58
52 Week High
$52.69
P/E
77.81x
P/B
4.76x
P/S
15.85x
PEG
2.14x
Dividend Yield
0.59%
Revenue
$55.68M
Earnings
$10.39M
Gross Margin
80.4%
Operating Margin
22.48%
Profit Margin
18.7%
Debt to Equity
0.06
Operating Cash Flow
$27M
Beta
0.9
Next Earnings
Oct 24, 2023
Ex-Dividend
N/A
Next Dividend
N/A

SLP Overview

Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, a quantitative systems pharmacology software; NAFLDsym; IPFsym; RENAsym; and MITOsym. In addition, the company provides Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as modeling and simulation products comprising MonolixSuite and PKPlus. Further, it provides population modeling and simulation contract research services; training and consulting services designed to accelerate pharmacometrics studies; and clinical-pharmacology-based consulting services in support of regulatory submissions. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how SLP scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

SLP ($40.46) is undervalued by 6.27% relative to our estimate of its Fair Value price of $43.17 based on Discounted Cash Flow (DCF) modelling, but does not have a significant margin of safety
Below Fair Value Valuation
SLP ($40.46) is not significantly undervalued (6.27%) relative to our estimate of its Fair Value price of $43.17 based on Discounted Cash Flow (DCF) modelling, when including a healthy margin of safety
Significantly Below Fair Value Valuation
SLP ($40.46) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation
There are 35 more SLP due diligence checks available for Premium users.

Be the first to know about important SLP news, forecast changes, insider trades & much more!

SLP News

Valuation

SLP fair value

Fair Value of SLP stock based on Discounted Cash Flow (DCF)
Price
$40.46
Fair Value
$43.17
Undervalued by
6.27%
SLP ($40.46) is undervalued by... subscribe to Premium to read more.
Below Fair Value Valuation
SLP ($40.46) is not significantly... subscribe to Premium to read more.
Significantly Below Fair Value Valuation
SLP ($40.46) is trading above... subscribe to Premium to read more.
Below Benjamin Graham Formula Value Valuation

SLP price to earnings (PE)

For valuing profitable companies with steady earnings
Company
77.81x
Industry
55.14x
Market
14.06x
SLP is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
SLP is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation

SLP price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
4.76x
Industry
3.07x
SLP is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation

SLP price to earnings growth (PEG)

For valuing profitable companies with growth potential
SLP is poor value relative... subscribe to Premium to read more.
PEG Value Valuation

SLP's financial health

Profit margin

Revenue
$16.2M
Net Income
$4.0M
Profit Margin
24.7%
SLP's Earnings (EBIT) of $12.52M... subscribe to Premium to read more.
Interest Coverage Financials
SLP's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$179.1M
Liabilities
$9.7M
Debt to equity
0.06
SLP's short-term assets ($137.31M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
SLP's short-term assets ($137.31M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
SLP's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
SLP's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$8.5M
Investing
$7.9M
Financing
-$628.0k
SLP's operating cash flow ($26.72M)... subscribe to Premium to read more.
Debt Coverage Financials

SLP vs Health Information Service Stocks

TickerMarket Cap1d %P/EP/B
SLP$806.24M-0.54%77.81x4.76x
ACCD$790.34M-2.43%-4.93x1.74x
AGTI$896.79M-2.50%221.33x0.94x
HSTM$652.09M-1.62%50.60x1.91x
PHR$973.88M-2.81%-6.17x3.94x

Simulations Plus Stock FAQ

What is Simulations Plus's quote symbol?

(NASDAQ: SLP) Simulations Plus trades on the NASDAQ under the ticker symbol SLP. Simulations Plus stock quotes can also be displayed as NASDAQ: SLP.

If you're new to stock investing, here's how to buy Simulations Plus stock.

What is the 52 week high and low for Simulations Plus (NASDAQ: SLP)?

(NASDAQ: SLP) Simulations Plus's 52-week high was $52.69, and its 52-week low was $32.58. It is currently -23.21% from its 52-week high and 24.21% from its 52-week low.

How much is Simulations Plus stock worth today?

(NASDAQ: SLP) Simulations Plus currently has 19,926,819 outstanding shares. With Simulations Plus stock trading at $40.46 per share, the total value of Simulations Plus stock (market capitalization) is $806.24M.

Simulations Plus stock was originally listed at a price of $1.06 in Dec 31, 1997. If you had invested in Simulations Plus stock at $1.06, your return over the last 25 years would have been 3,709.79%, for an annualized return of 15.67% (not including any dividends or dividend reinvestments).

How much is Simulations Plus's stock price per share?

(NASDAQ: SLP) Simulations Plus stock price per share is $40.46 today (as of Sep 26, 2023).

What is Simulations Plus's Market Cap?

(NASDAQ: SLP) Simulations Plus's market cap is $806.24M, as of Sep 28, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Simulations Plus's market cap is calculated by multiplying SLP's current stock price of $40.46 by SLP's total outstanding shares of 19,926,819.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.